We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Chemical Imaging Technique Developed to Help in the Fight against Atherosclerosis

By LabMedica International staff writers
Posted on 19 Aug 2009
A new chemical imaging technique could one day help in the fight against atherosclerosis, according to new research. More...


Atherosclerosis is the disease underlying most heart attacks and strokes and it is characterized by lesions in the arteries, made of fats, of collagen, and cells. The lesions cause artery walls to harden and thicken, which severely restricts the flow of blood around the body, and could rupture, leading to heart attacks and strokes. Understanding the precise chemical composition of an individual's lesions is important because the ones with higher levels of a type of fat, called cholesteryl ester are more prone to rupture.

The team of Imperial College London (UK) behind the new imaging technique, which is known as attenuated total reflection Fourier transform infrared spectroscopic imaging (ATR-FTIR imaging), believe that with further modifications, it could become a useful tool for physicians evaluating a patient's lesions. For example, by combining fiberoptic technology with ATR-FTIR imaging, the researchers believe clinicians could perform real-time inspections of patients with atherosclerosis, in order to assess the progress of the disease and establish which patients are at the greatest risk of complications.

Currently, physicians can use ultrasound to assess the size and location of lesions but they need to take biopsies of lesions in order to determine their chemistry. This is a complicated and invasive procedure. The researchers reported that the ATR-FTIR imaging could potentially improve current imaging techniques because it could combine imaging and chemical analysis, which would provide a concise and accurate image of a patient's lesions in one procedure. In the present study, the researchers demonstrated that ATR-FTIR imaging was able to reveal the precise composition and size of the lesions and the levels of elastin, collagen, and cholesteryl ester in them.

The ATR-FTIR imaging technology works by utilizing infrared light to identify different chemical molecules, which are mapped by an array detector to create a "chemical photograph.” The researchers used the technique to study the effects of age and an amino acid called L-arginine on the composition of lesions in cholesterol-fed laboratory rabbits. The work appeared to confirm that dietary L-arginine could remove lesions in the arteries of mature rabbits.

The researchers reported that additional research still needed to be done before the ATR-FTIR imaging could be used for patient care. They published their findings in the August 2009 issue of the Journal of the Royal Society Interface.

Lead-author, Prof. Sergei Kazarian, from the department of chemical engineering and chemical technology at Imperial College London, remarked, "Atherosclerosis can be a dangerous condition and our hope is that with further work, our approaches could ultimately be used to determine which patients are most at risk of complications. That way, doctors can target treatments at those patients who most need it, in order to prevent strokes and heart attacks.”

Related Links:

Imperial College London




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.